Literature DB >> 9424159

[10 years of cervix uteri cytologies in a health center].

J C Olazábal Ulacia1, J Montero Luengo, F Pastor Mateos, M J Alario García, R García Paniagua, J F García Gutiérrez.   

Abstract

OBJECTIVE: To evaluate results of the Papanicolaou cervical cytology test performed between 1986 and 1995.
DESIGN: A descriptive and retrospective study.
SETTING: Primary care, San Juan Health Centre, Salamanca. PARTICIPANTS: 1,271 women over 15 who had at least one smear during the study period. INTERVENTION: Review of clinical histories and cytology reports.
RESULTS: 2,056 smears were carried out. 50% were on women < 35, for whom family planning was the main reason for the test. Only 31% of the women between 35 and 65 had a smear. 35% of the women recruited had a further cytology test. 56% had morphological or microbiological disorders, 43.1% were negative and only 0.9% could not be evaluated by the pathologist. There were benign morphological alterations in 48.4% and infections in 27.3%. Only 15 smears (0.7%), corresponding to 12 women (1.2%), had suspected malignity, with dysplasia confirmed in 3 cases (0.24%).
CONCLUSIONS: There were few cases of cervical cancer detected with the methods followed at our centre. The effectiveness of the intervention should be improved by selective screening based on risk scales, setting up computerised systems of identification and the extension of the interval between smears to 5 years.

Entities:  

Mesh:

Year:  1997        PMID: 9424159

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  2 in total

1.  Increase in cervical cancer mortality in Spain, 1951-1991.

Authors:  J Llorca; M D Prieto; M Delgado-Rodríguez
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  [Use of pap smear for cervical cancer screening and factors related with its use in Spain].

Authors:  S Luengo Matos; A Muñoz van den Eynde
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.